• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Septerna, Inc. - Common Stock (NQ:SEPN)

25.30 -0.44 (-1.71%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Septerna, Inc. - Common Stock

News headline image
Septerna Expands Leadership with Appointment of Industry Veteran Mark A. Wilson as Chief Legal Officer
January 08, 2026
From Septerna, Inc.
Via GlobeNewswire
News headline image
Septerna to Present at 44th Annual J.P. Morgan Healthcare Conference
December 17, 2025
From Septerna, Inc.
Via GlobeNewswire
News headline image
Septerna to Participate in 8th Annual Evercore Healthcare Conference
November 25, 2025
From Septerna, Inc.
Via GlobeNewswire
News headline image
Septerna Highlights Company Progress and Reports Third Quarter 2025 Financial Results
November 10, 2025
From Septerna, Inc.
Via GlobeNewswire
News headline image
Septerna to Participate in Upcoming Investor Conferences
November 03, 2025
From Septerna, Inc.
Via GlobeNewswire
News headline image
Septerna Appoints Veteran Biotechnology Leader Keith Gottesdiener, M.D., to its Board of Directors
September 29, 2025
From Septerna, Inc.
Via GlobeNewswire
News headline image
Septerna to Participate in Upcoming Investor Conferences
August 27, 2025
From Septerna, Inc.
Via GlobeNewswire
News headline image
Septerna Announces Dosing of the First Participants in Phase 1 Clinical Trial of SEP-631, an Oral Small Molecule MRGPRX2 Negative Allosteric Modulator for the Treatment of Mast Cell-Driven Diseases
August 21, 2025
Trial Designed to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SEP-631 in Healthy Volunteers 
From Septerna, Inc.
Via GlobeNewswire
News headline image
Septerna Highlights Business Progress and Reports Second Quarter 2025 Financial Results
August 11, 2025
From Septerna, Inc.
Via GlobeNewswire
News headline image
Septerna to Present at Jefferies Global Healthcare Conference
May 29, 2025
From Septerna, Inc.
Via GlobeNewswire
News headline image
Septerna Highlights Business Progress and Reports First Quarter 2025 Financial Results
May 15, 2025
From Septerna, Inc.
Via GlobeNewswire
News headline image
Money Movers: HIT, SEPN, ALUR, LUCY, PRSO – Biotech, Healthcare, AI & Weight Loss Innovators Lead Momentum Surge – More Stocks Inside
May 14, 2025
Via AB Newswire
Topics Artificial Intelligence
News headline image
Septerna Provides Corporate Overview and Reports Fourth Quarter and Full Year 2024 Financial Results
March 27, 2025
From Septerna, Inc.
Via GlobeNewswire
News headline image
SEPN Investors Have Opportunity to Join Septerna, Inc. Fraud Investigation with the Schall Law Firm
March 18, 2025
From The Schall Law Firm
Via Business Wire
News headline image
Septerna to Present at TD Cowen 45th Annual Health Care Conference
February 26, 2025
From Septerna, Inc.
Via GlobeNewswire
News headline image
SEPTERNA ALERT: Bragar Eagel & Squire, P.C. is Investigating Septerna, Inc. on Behalf of Septerna Stockholders and Encourages Investors to Contact the Firm
February 21, 2025
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Septerna Announces Discontinuation of SEP-786 Phase 1 Clinical Trial and Plans to Advance Next-Generation Oral Small Molecule PTH1R Agonist
February 18, 2025
From Septerna, Inc.
Via GlobeNewswire
News headline image
Septerna Expands Leadership with Appointment of Industry Veteran Gil Labrucherie as Chief Financial Officer
January 06, 2025
From Septerna, Inc.
Via GlobeNewswire
News headline image
Septerna to Present at the 43rd Annual J.P. Morgan Healthcare Conference
December 18, 2024
From Septerna, Inc.
Via GlobeNewswire
News headline image
Septerna Reports Third Quarter 2024 Financial Results and Recent Business Highlights
November 20, 2024
From Septerna, Inc.
Via GlobeNewswire
News headline image
Septerna Announces Closing of $331.2 Million Upsized Initial Public Offering
October 30, 2024
From Septerna, Inc.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap